JBIO vs REGN: Which Stock is Better?

Side-by-side comparison of Jade Biosciences Inc and Regeneron Pharmaceuticals Inc in 2026

Comparison Updated:

JBIO

Jade Biosciences Inc

$22.85

REGN

Regeneron Pharmaceuticals Inc

$750.57

Key Metrics Comparison

MetricJBIOREGNWinner
Market Cap$1.13B$79.35BREGN
P/E RatioN/A18.08REGN
EPS (TTM)$N/A$41.51REGN
Revenue Growth0.0%0.0%REGN
Gross Margin0.0%44.6%REGN

Analyze JBIO

Full quant analysis

Analyze REGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is JBIO or REGN a better investment?

Comparing JBIO and REGN: Jade Biosciences Inc has a market cap of $1.13B while Regeneron Pharmaceuticals Inc has $79.35B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between JBIO and REGN?

JBIO (Jade Biosciences Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: JBIO or REGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: JBIO or REGN?

REGN has higher revenue growth at 0.0% vs 0.0% for JBIO.

Which company is more profitable: JBIO or REGN?

Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 44.6% compared to 0.0% for JBIO.

Which is the larger company: JBIO or REGN?

Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $79.35B compared to $1.13B for JBIO.

Should I buy JBIO or REGN in 2026?

Both JBIO and REGN have investment merit. JBIO trades at $22.85 while REGN trades at $750.57. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between JBIO and REGN stock?

Key differences: Market Cap ($1.13B vs $79.35B), P/E Ratio (N/A vs 18.1x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 44.6%).

Popular Stock Comparisons